{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:24:58Z","timestamp":1784676298009,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":6661,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.fertnstert.2003.07.027","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T05:36:34Z","timestamp":1079501794000},"page":"562-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization\u2013embryo transfer patients"],"prefix":"10.1016","volume":"81","author":[{"given":"Ernesto","family":"Escudero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Remoh\u0131\u0301","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pellicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2003.07.027_BIB1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0015-0282(01)01972-0","article-title":"Gonadotropin-releasing hormone antagonists instead of agonists","volume":"76","author":"Blumenfeld","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG","volume":"15","author":"Albano","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotropin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient","volume":"15","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB6","first-page":"1382","article-title":"Scheduled administration of GnRH antagonist (Cetrorelix) on day 8 of in vitro fertilization cycles","volume":"10","author":"Olivennes","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humrep\/14.suppl_1.207","article-title":"Ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection with gonadotropins and gonadotrophin-releasing hormone analogues","volume":"14","author":"Felberbaum","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in vitro fertilization-embryo transfer program","volume":"62","author":"Olivennes","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB10","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/oxfordjournals.humrep.a019058","article-title":"Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix)","volume":"11","author":"Albano","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotrophin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","article-title":"Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction","volume":"15","author":"Westergard","year":"2000","journal-title":"Hum Rep"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB13","doi-asserted-by":"crossref","unstructured":"Fleming R, Lloyd F, Herbert M, et al. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Rep 1998;13:1788\u201392","DOI":"10.1093\/humrep\/13.7.1788"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB14","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/humrep\/17.11.2842","article-title":"Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF","volume":"17","author":"Ludwig","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.humrep.a136889","article-title":"Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle","volume":"4","author":"Pellicer","year":"1989","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB16","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/oxfordjournals.humrep.a135880","article-title":"Efficacy of intracytoplasmic sperm injection using testicular spermatozoa","volume":"10","author":"Gil-Salom","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0301-2115(00)00535-2","article-title":"Gonadotropin-releasing hormone antagonist protocol","volume":"97","author":"Nikolettos","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2003.07.027_BIB18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/humrep\/16.5.868","article-title":"Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders","volume":"16","author":"Akman","year":"2001","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502820302898X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502820302898X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:23:43Z","timestamp":1777296223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502820302898X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S001502820302898X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2003.07.027","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization\u2013embryo transfer patients","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2003.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}